Myriad Genetics Inc (NASDAQ:MYGN)
| 26.12 Delayed Data As of May 10 |  -2.14 / -7.56%Today’s Change | 10.54 Today|||52-Week Range 33.97 | +32.06% Year-to-Date |
Largest transactions by value over
| Name | Type | Date | Shares traded | Share price | Transaction value | Since transaction |
|---|---|---|---|---|---|---|
Lanchbury Jerry S Chief Scientific Officer |  Sale | 2/16/2021 | 74,445 | $29.71 | $2.2M | -13.02% |
Lanchbury Jerry S Chief Scientific Officer |  Buy | 2/16/2021 | 74,445 | $18.00 | $1.3M | -13.02% |
Lanchbury Jerry S Chief Scientific Officer | Sale | 4/27/2021 | 40,000 | $31.47 | $1.3M | -14.76% |
Hart Jayne B Chief People Officer | Sale | 3/29/2021 | 28,000 | $30.00 | $840.0K | -9.62% |
Lanchbury Jerry S Chief Scientific Officer | Buy | 4/27/2021 | 40,000 | $19.47 | $778.8K | -14.76% |
Hart Jayne B Chief People Officer | Sale | 3/29/2021 | 21,966 | $30.00 | $659.0K | -9.62% |
Lanchbury Jerry S Chief Scientific Officer | Sale | 5/04/2021 | 19,360 | $31.97 | $618.9K | -17.43% |
Hart Jayne B Chief People Officer | Buy | 3/29/2021 | 21,966 | $24.89 | $546.7K | -9.62% |
Hart Jayne B Chief People Officer | Buy | 3/29/2021 | 28,000 | $19.47 | $545.2K | -9.62% |
Lanchbury Jerry S Chief Scientific Officer | Buy | 5/04/2021 | 19,360 | $19.47 | $376.9K | -17.43% |
Page of 9